Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PANTHERIndependent statistical analysis of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML): primary…
- Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835588).
- PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00088413).
- PAPALIndependent statistical analysis of A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667107).
- PAPIIndependent statistical analysis of Potency and Precision Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06240091).
- PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): Complete Statistical AnalysisIndependent statistical analysis of PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Paracervical Block During Office Hysteroscopy: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block During Office Hysteroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00811187).
- Paracervical Block for Pain Associated With Laminaria Insertion: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block for Pain Associated With Laminaria Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02454296).
- Paracervical Block Versus No Paracervical Block During IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Paracervical Block Versus No Paracervical Block During IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02904915).
- Paracetamol With Caffeine to Treat Episodic Tension Type Headache: Complete Statistical AnalysisIndependent statistical analysis of Paracetamol With Caffeine to Treat Episodic Tension Type Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755702).
- paradigm™5Independent statistical analysis of Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- paradigm™6Independent statistical analysis of Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PARADYSEIndependent statistical analysis of A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT: Complete Statistical AnalysisIndependent statistical analysis of Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02575079).
- PARAGON-HFIndependent statistical analysis of Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction: primary endpoint results, effect estimate with confidence interval,…
- Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD: Complete Statistical AnalysisIndependent statistical analysis of Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04111874).
- Parental Perceptions on Prescription Opioid Use: Complete Statistical AnalysisIndependent statistical analysis of Parental Perceptions on Prescription Opioid Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05344118).
- Parenting Support for Justice Involved Families: Complete Statistical AnalysisIndependent statistical analysis of Parenting Support for Justice Involved Families: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06329336).
- ParicalcitolIndependent statistical analysis of The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD: Complete Statistical AnalysisIndependent statistical analysis of Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PARQuitIndependent statistical analysis of PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950427).
- Parrying the Pitfalls of PrEP: Project PEACH: Complete Statistical AnalysisIndependent statistical analysis of Parrying the Pitfalls of PrEP: Project PEACH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05072093).
- PARTIndependent statistical analysis of PsA Treatment With hOKT3γ1 (Ala-Ala): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00239720).
- PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations: Complete Statistical AnalysisIndependent statistical analysis of PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations: Complete Statistical AnalysisIndependent statistical analysis of PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio’s HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs: Complete Statistical AnalysisIndependent statistical analysis of Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs: primary endpoint results, effect estimate with confidence interval,…
- Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris: primary endpoint results, effect estimate with confidence interval,…
- PArTNERIndependent statistical analysis of PATient Navigator to rEduce Readmissions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02114515).
- PARTNER-MHIndependent statistical analysis of Improving Patient-Provider Communication to Reduce Mental Health Disparities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04515771).
- Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers: Complete Statistical AnalysisIndependent statistical analysis of Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PARTRIDGEIndependent statistical analysis of A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment: primary endpoint results, effect estimate with confidence interval,…
- PASIndependent statistical analysis of Post Approval Study of the Eversense® Continuous Glucose Monitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03908125).
- PASIndependent statistical analysis of Pressure Alternating Shoes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06026813).
- PaSIndependent statistical analysis of Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06397443).
- PAS2Independent statistical analysis of Bronchial Thermoplasty in Severe Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01350336).
- PASCALRegistryIndependent statistical analysis of Edwards PASCAL Transcatheter Valve Repair System Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04443218).
- Pasos Hacia La Salud – Physical Activity Intervention for Latinas: Complete Statistical AnalysisIndependent statistical analysis of Pasos Hacia La Salud - Physical Activity Intervention for Latinas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01834287).
- PASSIndependent statistical analysis of Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PASS DEGENIndependent statistical analysis of The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PassItOnIndependent statistical analysis of Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PASSPORTIndependent statistical analysis of Study of BIIB092 in Participants With Progressive Supranuclear Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03068468).
- PATCHIndependent statistical analysis of Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PATCHIndependent statistical analysis of Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02855060).
- PATCHIndependent statistical analysis of The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04329923).
- Patch Test of Benzalkonium Chloride Disinfectant Spray: Complete Statistical AnalysisIndependent statistical analysis of Patch Test of Benzalkonium Chloride Disinfectant Spray: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01762982).
- PATCH-EDIndependent statistical analysis of Diagnostic Yield of an Ambulatory Patch Monitor in Unexplained Emergency Department Syncope: A Pilot Study (PATCH-ED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PATHIndependent statistical analysis of PATH Partnering to Achieve Tobacco-free Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01533974).
- PATHIndependent statistical analysis of Perindopril Amlodipine for the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01556997).
- PATH-MCIIndependent statistical analysis of Problem Adaptation Therapy for Mild Cognitive Impairment and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03043573).